Recent News

• 04.10.2025 - Keros Therapeutics Announces Review of Strategic Alternatives
• 04.10.2025 - Keros Therapeutics Announces Review of Strategic Alternatives
• 03.31.2025 - KER-065 Update Call
• 03.31.2025 - KER-065 Update Call
• 03.31.2025 - Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in Healthy Volunteers
• 03.31.2025 - Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in Healthy Volunteers
• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.03.2025 - TD Cowen 45th Annual Healthcare Conference
• 03.03.2025 - TD Cowen 45th Annual Healthcare Conference

Recent Filings

• 04.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - EX-99.1 EX-99.1
• 03.31.2025 - 8-K Current report
• 03.06.2025 - 8-K Current report
• 02.28.2025 - EX-99.1 EX-99.1
• 02.28.2025 - 8-K Current report